title: The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial).
authors.affiliation: The Department of Internal Medicine, Kyungpook University Hospital, Daegu, South Korea.
authors.forename: D K
authors.initials: DK
authors.lastname: Cho
authors.forename: J H
authors.initials: JH
authors.lastname: Kim
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: J C
authors.initials: JC
authors.lastname: Kim
authors.forename: C D
authors.initials: CD
authors.lastname: Kim
authors.forename: M Y
authors.initials: MY
authors.lastname: Baek
authors.forename: S J
authors.initials: SJ
authors.lastname: Kim
authors.forename: S H
authors.initials: SH
authors.lastname: Kim
authors.forename: T H
authors.initials: TH
authors.lastname: Kwon
authors.forename: Y L
authors.initials: YL
authors.lastname: Kim
authors.forename: Y W
authors.initials: YW
authors.lastname: Kim
authors.forename: S K
authors.initials: SK
authors.lastname: Chang
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use*; D012449:Safety
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone